Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
– Sell
-1,399
Closed -$20K – 9010
2015
Q2
$20K Buy
1,399
+433
+45% +$6.1K ﹤0.01% 6894
2015
Q1
$15K Buy
+966
New +$14.1K ﹤0.01% 7323
2014
Q3
– Sell
-4,186
Closed -$47K – 11199
2014
Q2
$47K Buy
+4,186
New +$45.1K ﹤0.01% 6971
2014
Q1
– Sell
-4,317
Closed -$43K – 11263
2013
Q4
$43K Buy
4,317
+3,449
+397% +$32.4K ﹤0.01% 7169
2013
Q3
$8K Sell
868
-4,428
-84% -$43.9K ﹤0.01% 9071
2013
Q2
$52K Hold
5,296
– – ﹤0.01% 6691

UBS Group's MCRL Position: Q3 2015 in Review

UBS Group sold out of Micrel (MCRL) in Q3 2015, closing a stake of 1,399 shares — an estimated $20K sold.

UBS Group first reported a position in MCRL in Q2 2013 and held it in 6 quarters. The position peaked at $52K in Q2 2013. 0 funds tracked by Wall St. Rank hold MCRL as of Q3 2015.

  • UBS Group reported no remaining Micrel position as of Q3 2015 after selling out during the quarter.
  • UBS Group sold 1,399 Micrel shares in Q3 2015, an estimated $20K.
  • UBS Group first reported a position in Micrel in Q2 2013 and held it in 6 quarters.
  • UBS Group's Micrel position peaked at $52K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held Micrel as of Q3 2015.

Based on UBS Group's 13F filing for Q3 2015, filed 13 Nov 2015.